AstraZeneca

Asthma attacks can be physically threatening and emotionally significant for many patients, and can be fatal. People with asthma are at risk of severe exacerbations regardless of disease severity or level of control. We are working to eliminate preventable asthma attacks by advancing treatment approaches. #TransformingRespiratoryCare

Tune in to hear Iskra Reic, EVP of Vaccines and Immune Therapies, on the latest HealthBeats podcast: https://learn.az/6042URWOY Iskra discusses the rising threat of non-communicable diseases (NCDs) with journalist Lara Setrakian in Abu Dhabi, highlighting her role with the PHSSR Steering Committee. NCDs cause 41 million deaths annually, deepen health inequities, strain health systems, and cost the global economy trillions. As populations age and climate change impacts vulnerable communities, screening, early detection, and treatment are crucial. Learn more in this insightful episode!

We’re delighted to win the award for Net Zero: Operations Transformation at the 2024 Reuters Sustainability Awards 🎉 AstraZeneca is recognised for driving deep decarbonisation across our operations and fleet through our over $1 billion Ambition Zero Carbon programme. By taking bold climate action, we aim to reduce Scope 1 and 2 greenhouse gas emissions by 98% by 2026 on the way to becoming net zero by 2045. And we’re making strong progress: by the end of 2023, we had reduced Scope 1 and 2 emissions by 67.6%. One of the ways we‘re doing this is by developing new sustainable sources of energy, including clean and renewable electricity. For example, we’re collaborating with Vanguard Renewables to enable 190 GWh per year or renewable natural gas to be used across our US sites, and in the UK, we’re partnering with Future Biogas to supply 100 GWh per year of biomethane to our UK sites. Find out more about our sustainability impact and how we’re accelerating the delivery of resilient, equitable and net zero healthcare: https://learn.az/6042UV7e8

Στην AstraZeneca Ελλάδας κινούμαστε 100% με ηλεκτρικά οχήματα, καθώς ολοκληρώσαμε με επιτυχία τη μετάβαση του στόλου μας στην ηλεκτροκίνηση αντικαθιστώντας 230 οχήματα με ηλεκτρικά. Επιπλέον, εγκαταστήσαμε 42 φορτιστές στα γραφεία μας στην Αθήνα και επιδοτήσαμε έως και το σύνολο του κόστους για την εγκατάσταση φορτιστών στις κατοικίες των εργαζομένων που το επιθυμούν. Αυτή η κίνηση αποτελεί μέρος της διεθνούς μας δέσμευσης Ambition Zero Carbon, που στοχεύει σε μηδενικές εκπομπές άνθρακα παγκοσμίως έως το 2025, προωθώντας ένα πιο βιώσιμο μέλλον. Μπορείτε να επισκεφθείτε το https://lnkd.in/dUsbH6up για περισσότερες πληροφορίες. #EVs #EV100

We are working to advance liver cancer treatments that give patients options for long-term survival and better quality of life. Meet Andrea from Blue Faery: The Adrienne Wilson Liver Cancer Association which aims to raise awareness of clinical trials, treatment options, and assistance programs for patients with liver cancers. Together we aim to one day eliminate GI cancers. #LiverCancerAwarenessMonth

One year can change everything. A 12-month delay in diagnosing stage 3 chronic kidney disease (CKD) raises the risk of needing a kidney transplant or long-term dialysis treatment by 63%. We must act now. At #UNGA79, we— alongside Boehringer Ingelheim and partners the International Society of Nephrology, Global Patient Alliance for Kidney Health, and Devex — brought together global experts to call for CKD to be recognised as an urgent global health priority. Together, we explored how early detection, diagnosis, treatment and care can make a difference. Together, we can make the change. Sign up to learn more: https://learn.az/6045U3gPl #ForKidneyHealth

Digital biomarkers have the potential to help researchers more effectively study rare diseases by providing a better understanding of symptoms and treatment response. Christophe Hotermans, MD PhD, Head of Global Medical Affairs Alexion Pharmaceuticals, Inc. discusses how digital biomarker data can help accelerate the discovery and development of new medicines. Learn more: https://learn.az/6044UOymr #ClinicalInnovation #WhatScienceCanDo

Our Employee resource groups (ERG’s) are designed to support our diverse workforce by promoting a sense of belonging, enabling our employees to share knowledge and help drive positive change on a variety of workplace issues. The Network of Women and Allies is a growing global community designed to support and champion women in the workplace throughout their lives and careers. Learn how one of our workstreams, Menopause & Me, is helping create a supportive environment for colleagues experiencing personal change: https://learn.az/6042Uzh9r #ERG #HealthandWellbeing #LifeatAZ

Our recent publication in Nature Communications reports the function of the enzyme PNPLA3 in balancing lipid levels in the liver and bloodstream. By understanding how loss of function of this enzyme could drive progression of steatotic liver disease, including metabolic dysfunction-associated steatohepatitis (MASH), our scientists are aiming to identify new therapeutic approaches for patients living with this disease. Learn more here: https://learn.az/6049U8RXF

We're playing our part to deliver better healthcare outcomes with a lower environmental footprint. By harnessing the power of sustainable science, and in partnership with ERM, we’re decarbonising our clinical trials and accelerating progress towards net zero healthcare. 🌍 Learn more: https://learn.az/6048WHlyk #WhatScienceCanDo